Inventor · disambiguated record
Nino Devidze
Also filed as: DEVIDZE NINO
6 granted patents·4 pending applications·10 citations·filing 2018–2025
77Inventor score
Top patents by PatentIndex Score
10 records- 0195US11359197B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 14, 2022·4 cites·18 claims
- 0289US11447775B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·3 cites·20 claims
- 0388US2025136988A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0483US11827695B2Antibodies to alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 28, 2023·1 cites·16 claims
- 0581US12180478B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0676US11142570B2Antibodies to alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 12, 2021·2 cites·28 claims
- 0774US2025327072A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0863US12241065B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 0962US2025188463A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1058US2024390521A1Chimeric modified ion channels and uses thereof for treatment of trigeminal nerve disordersKRIYA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nino Devidze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →